Related Experiment Video
Updated: Aug 14, 2026

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
Published on: June 19, 2018
Prepared or at-risk? Evaluating live viral vaccine coverage and vaccine immunogenicity before pediatric solid organ
Benhur Sirvan Cetin1,2, Caitlin Brammer2, William Otto2,3
1Department of Pediatric Infectious Diseases, Faculty of Medicine, Erciyes University, Kayseri, Türkiye.
Insights
Many pediatric transplant candidates lack crucial vaccines for measles and varicella before their surgery. Infants and those awaiting liver or heart transplants show the lowest vaccination rates, increasing their risk.
Area of Science:
- Immunology
- Pediatric Medicine
- Transplantation
Background:
- Pediatric solid organ transplant recipients face significant risks from vaccine-preventable diseases.
- Pre-transplant vaccination coverage in this vulnerable population is frequently inconsistent.
- Maintaining adequate immunity is critical for post-transplant outcomes.
Purpose of the Study:
- To evaluate vaccination status and serologic immunity for varicella and measles in pediatric transplant candidates.
- To identify trends in vaccination coverage from initial evaluation through transplantation.
- To assess factors associated with incomplete vaccination and seronegativity.
Main Methods:
- Retrospective cohort study of 421 pediatric transplant recipients (2018-2024).
- Analysis of vaccination status and serologic immunity for varicella and measles at key pre-transplant points.
- Comparison of vaccination rates across different transplant types and age groups.
Main Results:
- At transplant, 19.2% were under-vaccinated for varicella and 21.6% for measles, with infants most affected.
- A notable percentage (7.1% varicella, 8.6% measles) lost vaccination status pre-transplant.
- Kidney recipients had high vaccination rates (>94%), while liver and heart recipients had lower rates (58%-72%).
- Seronegativity was observed in 23.6% for varicella and 13.0% for measles among fully vaccinated patients.
Conclusions:
- Many pediatric transplant candidates, especially infants and those awaiting liver/heart transplants, are incompletely vaccinated.
- Dynamic changes in vaccination status pre-transplant necessitate continuous monitoring.
- Improved vaccination strategies are urgently needed to protect this high-risk population.
Abstract:
Pediatric solid organ transplant recipients are at high risk for complications from vaccine-preventable diseases, yet pre-transplant vaccination coverage is often inconsistent. We conducted a retrospective cohort study of 421 pediatric transplant recipients between 2018 and 2024 to evaluate vaccination status and serologic immunity for varicella and measles at the time of initial evaluation, listing, and transplantation. At the time of transplant, 19.2% of patients for varicella and 21.6% for measles were under-vaccinated, with infants having the highest rates of incomplete vaccination. A portion of patients (7.1% for varicella, 8.6% for measles) transitioned from full to incomplete vaccination status during the pre-transplant period, a change associated with a shorter time from evaluation to listing. Kidney recipients had the highest completed vaccination rates (>94%), whereas rates for liver and heart recipients were substantially lower (58%-72%). Among fully vaccinated patients, seronegativity was observed for varicella (23.6%) and measles (13.0%). In conclusion, many pediatric transplant candidates, particularly infants and those awaiting liver or heart transplant, are incompletely vaccinated. A dynamic change in vaccination status from evaluation to transplant highlights an urgent need for continuous monitoring and improved strategies to protect these vulnerable children.
More Related Videos
08:04Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
Published on: July 9, 2014
06:32A Neonatal Intravenous Transplant Model for Assessment of Early-Life Immune Activities Against Cancer Cells
Published on: June 26, 2026
Related Concept Videos
Kidney Transplant I: Introduction
Vaccinations
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Vaccines
Transmission-based Precautions I: Contact, Enteric, and Droplets
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Kidney Transplant III: Nursing Management